Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285
million people with diabetes mellitus worldwide, approximately one third have signs of DR …

The target audience for the Standards of Care includes primary care physicians,
endocrinologists, nurse practitioners, physician associates/assistants, pharmacists …

It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic
required, but also for its major complications, affecting both small and large blood vessels …

OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy
(DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes …

Importance Diabetic macular edema (DME) is a leading cause of vision loss in persons with
diabetes mellitus. Although there are national estimates for the prevalence of diabetic …

Objective To determine the prevalence of diabetic retinopathy among adults 40 years and
older in the United States. Methods Pooled analysis of data from 8 population-based eye …

Diabetes mellitus (DM) has become a vital societal problem as epidemiological studies
demonstrate the increasing incidence of type 1 and type 2 diabetes. Lesions observed in the …

Background Diabetic retinopathy is a common complication of diabetes and a leading cause
of visual impairment and blindness. Research has established the importance of blood …

Purpose Diabetic retinopathy (DR) can lead to significant vision loss and blindness and has
a particularly high prevalence in patients with type 1 diabetes (DM 1). In this study, we …